NASDAQ: XFORX4 Pharmaceuticals Inc Stock Ownership - Who owns X4 Pharmaceuticals?
Insider buying vs selling
Have X4 Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adam R. Craig | Executive Chairman | 2025-10-23 | 86,206 | $2.90 | $250.00kBuy |
| Mark Baldry | Chief Commercial Officer | 2025-05-16 | 1,032 | $2.48 | $2.56kBuy |
| Mark Baldry | Chief Commercial Officer | 2025-05-16 | 1,032 | $2.48 | $2.56kBuy |
XFOR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XFOR insiders and whales buy or sell their stock.
XFOR Shareholders
What type of owners hold X4 Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Paula Ragan | 3.82% | 3,337,386 | $12.08M | Insider |
| Bain Capital Life Sciences Investors LLC | 2.79% | 2,436,588 | $8.82M | Institution |
| Nea Management Company LLC | 2.55% | 2,233,743 | $8.09M | Institution |
| Bvf Inc | 2.55% | 2,233,742 | $8.09M | Institution |
| Nantahala Capital Management LLC | 2.55% | 2,228,350 | $8.07M | Institution |
| Rosalind Advisors Inc | 1.77% | 1,544,607 | $5.59M | Institution |
| Mary Dibiase | 1.30% | 1,140,980 | $4.13M | Insider |
| Deep Track Capital LP | 1.28% | 1,122,484 | $4.06M | Institution |
| Stonepine Capital Management LLC | 1.21% | 1,056,338 | $3.82M | Institution |
| Kingdon Capital Management LLC | 1.07% | 933,332 | $3.38M | Institution |
XFOR vs Biotech Stocks
X4 Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.